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Abstract
Aims/hypothesis Previous Danish twin studies have found a
highly increased risk of precursors of type 2 diabetes as
well as a higher prevalence of type 2 diabetes among twins
compared with singletons. Likewise, small-scale studies of
Danish twins have shown that monozygotic twins have a
higher risk of developing precursors of type 2 diabetes
compared with dizygotic twins. In the present register-
based study, the 10 year period diabetes prevalence in
Danish twins is compared with that in a random sample of
Danish citizens. Furthermore, the 10 year period prevalence
of diabetes in monozygotic twins is compared with that in
dizygotic twins.
Methods The study population consisted of twins (n=77,885)
identified in the Danish Twin Registry, and a 5% random
sample (n=215,264) from the birth cohorts 1910–1989. We
identified diabetes patients by means of three nationwide
Danish health registers.
Results The number of identified diabetes cases among
males was 6,677 (6.24%) for singletons vs 2,271 (5.68%)
for twins (difference=0.56% [0.29–0.83%]). The number
among females was 6,143 (5.67%) for singletons and 1,722
(4.54%) for twins (difference=1.13% [0.88–0.38%]). Re-
striction to various birth cohorts, known zygosity and
known type 2 diabetes did not alter the overall conclusions.
The difference between monozygotic twins (males, 5.29%;
females, 4.40%) and dizygotic twins (males, 5.77%;
females, 4.63%) was non-significant.
Conclusions/interpretation Danish twins do not have an
increased risk of developing diabetes compared with
singletons, and the risk of diabetes among monozygotic
twins does not differ from that of dizygotic twins.
Keywords 10 year period prevalence . Diabetes .
Heritability . Register-based study . Singletons . Twins
Abbreviations
AIC Akaike’s information criterion
ATC Anatomical Therapeutic Chemical Classification
System
CPR Central Person Register
DTR Danish Twin Registry
DZ Dizygotic
MZ Monozygotic
osDZ Opposite-sex dizygotic
ssDZ Same-sex dizygotic
UZ Unknown zygosity
Introduction
The fetal origins hypothesis states that fetal undernutrition
in middle-to-late gestation programmes for a higher
susceptibility of developing adverse health outcomes such
as hypertension, coronary heart diseases, impaired glucose
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tolerance and type 2 diabetes [1]. Birthweight is, though not
fully sufficient, an easily obtainable summary measure of
fetal growth and has therefore been widely used when
investigating the validity of the fetal origins hypothesis.
Hence several studies have provided evidence of an inverse
association between birthweight and coronary heart disease
[2, 3], blood pressure [4], and risk of developing type 2
diabetes [5, 6]. While the association between birthweight
and adverse health outcomes in adult life has been
confirmed in several studies, the underlying reason for the
link between these phenotypes is still under debate. The
thrifty phenotype hypothesis claims that poor nutrition in
late gestation permanently alters the metabolism, thereby
causing a higher susceptibility of developing type 2
diabetes in adult life [7, 8]. On the other hand, the fetal
insulin hypothesis proposes that the inverse association
between impaired fetal growth and susceptibility to devel-
oping type 2 diabetes in adult life is predominantly driven
by genetic confounding (pleiotropy): i.e. common genetic
factors affecting both fetal growth and susceptibility to type 2
diabetes [9].
The low birthweight of twins compared with singletons
(mean difference, 900 g) [10–12] has caused concern that
twins per se face a higher risk of developing type 2 diabetes
in adult life compared with singletons [13]. Previous small-
scale studies of Danish twins drawn from the Danish Twin
Registry (DTR) have demonstrated that twins have a higher
incidence and prevalence of type 2 diabetes [14] as well as
a higher prevalence of precursors of type 2 diabetes [14–16]
compared with singletons. It has been argued that these
results are caused by factors associated with lower birth-
weight of twins [17]. Similar results were found in a small
study of insulin resistance in prepubertal twins and single-
tons from New Zealand, [18] while studies of adult Scots
did not find evidence of twin–singleton differences in
prediabetic disorders [19, 20]. In a large study of self-
reported diabetes among 18,230 Swedish twins from birth
cohorts 1926–1958, the authors observe the same overall
prevalence of type 2 diabetes as that reported in the general
population by the Swedish National Board of Health [21].
Prevalence figures for diabetes in twins stratified for birth
cohorts in two Swedish studies [21, 22] were similar to that
found in a large-scale study based on data from the Finnish
Twin Registry [23].
It has been hypothesised that monozygotic (MZ) twins
exhibit more features of the metabolic syndrome and type 2
diabetes than dizygotic (DZ) twins [15]. This difference is
thought to have its origin in the fact that two-thirds of MZ
twins are monochorionic and thus share the source of
nutrition in the womb, causing a potentially more adverse
intrauterine environment for these fetuses [15]. While only
small differences in prevalence of type 2 diabetes are
reported in large-scale studies based on data from the
Finnish [23] and Swedish [21, 22] twin registries, a number
of small-scale studies of Danish twins provide support for a
higher susceptibility of developing type 2 diabetes among
MZ compared with DZ twins [16, 24–27]. The results of
the small Danish studies may be chance findings due to
varying classifications, outcomes and small sample sizes, or
they may reflect a real difference between the Nordic
countries based on different risk profiles: for example,
despite closeness in geography, healthcare and social
systems, the life expectancy in Sweden is 3 years longer
than in Denmark, mainly because of differences in smoking
rates [28, 29].
Here we report a nationwide register-based study
including 77,885 twins (17,331 MZ, 27,951 same-sex (ss)
DZ, 24,917 opposite-sex (os)DZ, and 7,686 of unknown
zygosity (UZ)) and a random 5% sample of the Danish
population consisting of 215,264 singletons, all followed
for 10 years through national Danish health registers.
Methods
Materials
The Danish Twin Registry The DTR comprises more than
80,000 Danish twin pairs from the birth cohorts 1870–
2005. The recruitment procedures for the DTR have been
thoroughly described by Skytthe et al. [30]. The twin birth
cohorts 1870–2001 registered in the DTR and surviving
until the start-up of the Central Person Register (CPR) at
2 April 1968, or born thereafter, have been linked to several
administrative databases held at Statistics Denmark.
Zygosity Zygosity determination of the twins is based on
mail-back questionnaires of physical similarities; a method
that has proven to give rise to a misclassification of less
than 5% [31]. Zygosity information was unknown, because
of either missing or contradictory responses to the ques-
tionnaire, in 9.9% of the twin pairs.
5% random sample In addition, we have information on a
5% random sample of each Danish birth cohort from 1870
to 2001 who were all alive and resident in Denmark at the
start of the CPR (2 April 1968), or born or immigrated
thereafter.
Linkage Linkage between all registries is feasible because
of a unique ten-digit personal identification number
assigned to all Danish residents at 2 April 1968.
Data In the present study we constrain the data to Danish-
born non-emigrated individuals from birth cohorts 1910–
1989, leaving 77,885 twins and 215,264 singletons alive
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and resident in Denmark at 1 January 1997. Birth country
was localised by means of the Danish Demographic
Database [32] supplemented by information from the CPR
when information in the Danish Demographic Database
was absent. Identification of Danish residents on 1 January
1997 was based on information on individuals included in
the Integrated Database for Labor Market Research 1996,
[33] which contains all Danish residents on 1 January the
following year.
Identification of diabetes patients For both twins and
singletons it is possible to identify all hospitalised patients
with a diabetes diagnosis since the start of the National
Patient Register in 1977. Additional tracking was made
feasible using the Register of Medicinal Product Statistics,
[34] which covers all subsidised redeemed prescriptions
since 1995 and, from 1997, the Danish National Health
Service Register, which holds information on all contacts to
general practitioners, specialist doctors, and subsidised
treatments conducted by, for example, podiatrists [35]. We
have used the procedure [36] introduced by the Danish
National Board of Health to identify diabetes patients in the
Danish healthcare system from: (1) ICD-10 codes E10,
E11, E12, E13, E14, O24, and H360 (www.who.int/
classifications/icd/en/) in the Danish National Patient
Register (excluding gestational diabetes [code O244]);
(2) the primary healthcare system via the Danish National
Health Service Register if a patient had five blood glucose
measurements within a calendar year, or two glucose
measurements each year for five consecutive years, or a
podiatry treatment; and (3) redeemed prescriptions for insulin
(Anatomical Therapeutic Chemical Classification System
[ATC] code A10A*) or glucose-lowering agents (ATC codes
A10B*), at a minimum of two within a half year. We have
identified all registered occurrences of diabetes within the
period 1997–2006 according to these definitions (i.e. in a
similar manner to the procedures used by the Danish National
Board of Health, we excluded diabetes cases from before all
three registries were accessible in 1997).
It is not possible to distinguish between patients with
type 1 and 2 diabetes based on information from the Danish
Health Registers. However, we identified all patients who
had ever redeemed a prescription for oral glucose-lowering
agents (ATC codes A10B*) or been assigned a non-insulin
dependent diagnosis (E11) as patients suffering from type 2
diabetes. This approach of classifying diabetes into type 1
and type 2 is close to the one used by Iliadou et al. in their
study of diabetes in 11,162 Swedish twins [22].
Statistical methods
The 10 year period prevalence of diabetes stratified for
10 year birth cohorts, sex and twin/singleton status as well
as zygosity (MZ vs DZ) was calculated. Fisher’s exact test
was used to test for differences of 10 year period prevalence
of diabetes between groups (i.e. equality of 10 year period
prevalence of diabetes in twins vs singletons as well as MZ
vs DZ).
All analyses were repeated: (1) after restriction to known
type 2 diabetes cases; and (2) after exclusion of UZ twins
(9.9%).
Stata 11 [37] was used for all analyses except for
structural equation modelling, which was performed using
the Mx software [38].
Validation The Danish National Board of Health has
established the Danish National Diabetes Register based
on the same registers and methods as the ones used in the
present study, and it publishes an annual report on the
prevalence of diabetes within the total Danish population
[36]. We restricted the sample to individuals alive on
1 January 2007 who had been resident in Denmark during
the 10 year period 1997–2007, leaving 69,118 (89.4%)
twins and 183,870 (86.4%) singletons. We compared the
age- and sex-stratified prevalence with the 2009 report from
the National Board of Health (reporting diabetes prevalence
at 1 January 2007) [36] in order to validate our data and
methods.
Heritability estimates To further test the validity of the data
we calculated the heritability of 10 year period diabetes
prevalence to compare with estimates based on studies of
the Finnish Twin Registry. Sex-specific correlations of
liability and heritability estimates were calculated for
complete MZ and ssDZ pairs. Structural equation model-
ling techniques based on threshold models and using the
Mx software [38] were implemented for the assessment of
correlations of liability as well as heritability estimates.
Using these models it is assumed that the total variation can
be decomposed as V ¼ Aþ Cþ Dþ E (A, additive genet-
ic; C, shared environment; D, genetic dominance; and E,
non-shared environment). Furthermore, it is assumed that
gene–gene and gene–environment interactions are absent.
As the ACDE model is under-identified, C and D cannot be
estimated simultaneously, thus ACE, ADE, and sub-models
of these were fitted to the data. Best-fitting models were
chosen as those with the lowest Akaike’s information
criterion AIC ¼ 2loglikelihood 2dfð Þ.
Informed consent
The study was based on secondary data analyses of
register data, hence no informed consent from the
participants was needed. The project was approved by
the Danish Data Protection Agency (journal number
2007-41-1317).
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Results
We identified 16,813 (5.7%) diabetes patients, of whom
6,677 were male singletons, 2,271 were male twins, 6,143
were female singletons and 1,722 were female twins. Tables 1
and 2 show the mean values and SD for age and number of
individuals alive on 1 January 1997 within 10 year birth
cohorts stratified for sex and twin/singleton status for males
and females, respectively. The numbers demonstrate that
small and non-systematic differences in the age distribution
of twins and singletons are present as expected from
previous work showing that twins have an adult mortality
similar to that of singletons [39]. Percentages of individuals
exiting the study population before 2007, because of either
death or migration in the period from 1997 to 2007, stratified
for 10 year birth cohorts and twin/singleton status, are
reported in Fig. 1. The figure illustrates that there are no
systematic differences in loss through death and migration
between the twin and the singleton populations. Stratification
for sex did not alter these conclusions (results not shown.)
The 10 year period prevalence (1997–2006) as well as 95%
CIs of all Danish-born individuals alive on 1 January 1997
stratified for sex, 10 year birth cohorts and twin/singleton
status is shown in Fig. 2. The results reveal no difference in
10 year period prevalence between twins and singletons,
only a tendency towards a higher 10 year period prevalence
of diabetes in twins compared with singletons among men
from birth cohorts 1910–1939 and women from birth cohorts
1910–1929. For birth cohorts born after 1940 we find the
opposite tendency, but the differences are small and mainly
not statistically significant. Figure 3 shows the 10 year
period prevalence and 95% CIs of individuals with known
type 2 diabetes stratified for sex, 10 year birth cohorts and
twin/singleton status. The results reveal the same pattern as
for all diabetes cases (Fig. 2) except that the difference for
men in birth cohorts 1920–1929 is now statistically
significant (difference is 1.91% [95% CI=0.12–3.70%]).
Figure 4 reports the 10 year period prevalence of
diabetes stratified by 10 year birth cohorts, sex and zygosity
(MZ vs osDZ/ssDZ). The only statistically significant
difference in favour of a higher diabetes prevalence among
MZ twins compared with DZ twins is found in the male
1980–1989 birth cohorts (1.4% vs 0.3%), but based on only
22 diabetic twins. As these patients were 18–28 years of
Table 1 Number and age of male twins and singletons alive and resident in Denmark on 1 January 1997 and number with diabetes
Birth cohort Twins Singletons
n Age (mean±SD) Diabetes cases, n (%) n Age (mean±SD) Diabetes cases, n (%) p valuea
1910–1919 675 81.4±2.9 92 (13.6) 4,233 81.2±2.7 539 (12.7) 0.54
1920–1929 1,573 71.7±2.8 269 (17.1) 8,624 71.7±2.9 1,335 (15.5) 0.11
1930–1939 4,686 61.5±2.8 719 (15.3) 11,411 61.7±2.9 1,674 (14.7) 0.28
1940–1949 7,587 51.6±2.8 683 (9.0) 17,378 51.7±2.8 1,687 (9.7) 0.08
1950–1959 6,631 42.0±3.0 289 (4.4) 17,103 42.0±2.9 797 (4.7) 0.33
1960–1969 7,159 32.1±2.8 140 (2.0) 18,165 32.0±2.8 416 (2.3) 0.11
1970–1979 6,103 22.1±2.9 46 (0.8) 16,346 22.2±2.8 161 (1.0) 0.12
1980–1989 5,559 11.9±2.9 33 (0.6) 13,689 11.9±2.9 68 (0.5) 0.44
a p value for equal 10 year period diabetes prevalence among twins and singletons (Fisher’s exact test)
Table 2 Number and age of female twins and singletons alive and resident in Denmark on 1 January 1997 and number with diabetes
Birth cohort Twins Singletons
n Age (mean±SD) Diabetes cases, n (%) n Age (mean±SD) Diabetes cases, n (%) p valuea
1910–1919 1,325 81.5±2.9 180 (13.6) 6,789 81.5±2.8 838 (12.3) 0.22
1920–1929 2,123 71.9±2.9 304 (14.3) 10,650 72.0±2.9 1,503 (14.1) 0.81
1930–1939 4,097 61.6±2.7 459 (11.2) 11,761 61.8±2.9 1,380 (11.7) 0.38
1940–1949 6,568 51.7±2.8 399 (6.1) 17,043 51.8±2.8 1,105 (6.5) 0.26
1950–1959 5,506 42.1±3.1 153 (2.8) 16,432 42.1±2.9 567 (3.5) 0.02
1960–1969 7,223 32.1±2.8 122 (1.7) 17,270 32.0±2.8 346 (2.0) 0.11
1970–1979 5,692 22.1±2.8 85 (1.5) 15,561 22.2±2.8 293 (1.9) 0.06
1980–1989 5,378 11.7±2.9 20 (0.4) 12,800 11.9±2.9 111 (0.9) <0.01
a p value for equal 10 year period diabetes prevalence among twins and singletons (Fisher’s exact test)
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age in 2006, the majority of these cases are patients
suffering from type 1 diabetes.
Restricting our sample to individuals resident in
Denmark during the 10 year observation period demon-
strated similar age and sex-specific prevalence on
1 January 2007 as the ones estimated on the basis of
the established Danish National Diabetes Register [36,
40] (results not shown). Thus, we conclude that our data
and methods are in agreement with those of the National
Board of Health used to create the Danish National
Diabetes Register [36].
Re-running the analyses after exclusion of twins with
unknown zygosity as well as only including cases with
known type 2 diabetes gave nearly identical results and did
not alter the overall conclusions of the present study (results
not shown).
We repeated the analyses in birth cohorts 1921–1940,
including only MZ and ssDZ twins, in order to retrieve
results that could be compared directly with results from
previous Danish studies of twins and singletons [14, 16,
25–27]. These sub-analyses demonstrated no twin–single-
ton differences in overall 10 year diabetes prevalence
among males (twins, 15.7%; singletons, 14.9%; p=0.23);
or females (twins, 12.5%; singletons, 12.5%; p=0.98).
Neither could we demonstrate any statistically significant
difference, despite the large sample size, in 10 year period
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Fig. 2 The 10 year period prevalence of diabetes, stratified for sex,
10 year birth cohort intervals and twin/singleton status in (a) males
and (b) females. *p<0.05. Population is Danish-born individuals who
were alive on 1 January 1997. Singletons, triangles; twins, circles.
Vertical bars indicate 95% CIs
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Fig. 3 The 10 year period prevalence of known type 2 diabetes
(patients who had ever redeemed a prescription for glucose-lowering
agents or been ascribed a non-insulin-dependent diagnosis), stratified
for sex, 10 year birth cohort intervals, and twin/singleton status in
(a) males and (b) females. *p<0.05. Population is Danish-born
individuals who were alive on 1 January 1997. Singletons, triangles;
twins, circles. Vertical bars indicate 95% CIs
*
*
0
0.05
0.1
0.15
0.2
Pe
rio
d 
pr
ev
al
en
ce
19
10
−
19
19
20
−
29
19
30
−
39
19
40
−
49
19
50
−
59
19
60
−
69
19
70
−
79
19
80
−
89
Birth cohort
0
0.05
0.1
0.15
0.2
Pe
rio
d 
pr
ev
al
en
ce
19
10
−
19
19
20
−
29
19
30
−
39
19
40
−
49
19
50
−
59
19
60
−
69
19
70
−
79
19
80
−
89
Birth cohort
a b
Fig. 4 The 10 year period prevalence of diabetes stratified for sex,
10 year birth cohort intervals, and zygosity (MZ vs osDZ/ssDZ) in
(a) males and (b) females. *p<0.05. Population is Danish-born
individuals who were alive on 1 January 1997. osDZ/ssDZ, triangles;
MZ, circles. Vertical bars indicate 95% CIs
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Fig. 1 Proportion of Danish-born twins (T) and singletons (S) present
on 1 January 1997 who were alive and had not emigrated during the
10 year period (1997–2006, black), who had emigrated for any period
in the 10 year observation time (white), and who had died (grey)
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diabetes prevalence in MZ vs ssDZ twins (males, 16.9% vs
15.1%, p=0.16; females, 12.9% vs 12.3%, p=0.59).
Heritability estimates Structural equations modelling was
carried out on 8,092 MZ pairs (4,124 female and 3,968
male pairs) and 12,557 ssDZ pairs (6,128 female and 6,429
male pairs). The sex-specific correlations of liability were
significantly higher for MZ twins than for ssDZ twins
(males, 0.79 vs 0.39 [p<0.001]; females, 0.70 vs 0.39
[p<0.001]), thus indicating a genetic contribution to the
observed variance of diabetes for both sexes. Model-fit
statistics as well as heritability estimates for all biometric
models are reported in Tables 3 and 4. The AE model
demonstrated the best fit for both sexes and the estimated
heritability was 0.79 (95% CI 0.74–0.84) for males and
slightly lower (0.71 [95% CI 0.64–0.77]) for females. The
heritability estimate of known type 2 diabetes among
females was similar to the estimates for all diabetes cases,
but was slightly lower for males (0.72 [95% CI 0.60–0.78]).
Discussion
In the comparison study of 77,885 twins and 215,264
singletons from the Danish birth cohorts 1910–1989 we did
not find evidence of an increased risk of diabetes in twins.
Neither did we find any difference of diabetes prevalence
between MZ and DZ twins.
Several small-scale studies involving clinical examina-
tions have demonstrated that twins face a higher risk of
developing metabolic abnormalities: lower insulin sensitiv-
ity of twins compared with singletons in prepubertal
children (50 twins and 20 singletons) from New Zealand
[18], measures from an OGTT test of 297 twins and 71
singletons from Denmark (birth cohorts 1921–1940) [14],
results from clamp examination of 86 twins and 17 age-
matched spouses from Danish birth cohorts 1931–1940
[16], and measures from OGTTs of 48 MZ twins and 50
singletons from Italy (mean age, 33 years) [41]. Conversely,
no evidence of differences in several outcomes within the
metabolic syndrome was found in a clinical examination of
131 adult twin pairs and 89 singletons [19, 20].
Johansson et al. studied the prevalence of self-reported
type 2 diabetes among 18,442 twins from birth cohorts
1926–1958 and found the same type 2 diabetes prevalence
among Swedish same-sex twins (3.2%) as in the back-
ground population [21]. Iliadou et al. estimated a slightly
higher type 2 diabetes prevalence (3.7%) among 11,162
Swedish same-sex twins from birth cohorts 1906–1958
[22]. Likewise, Kaprio et al. identified diabetes cases by
means of two national health registers (data on hospital
discharges and Registry of the Social Insurance Institution
for reimbursement of free-of-charge medication) of 13,888
Finnish same-sex twin pairs born prior to 1958 [23]. The
estimated cumulative incidence in the Finnish study was
2.7%. Furthermore, the three studies reported approximately
the same prevalence of diabetes in the age range 40–75 years.
We estimated the prevalence (based on the cumulative
prevalence on 1 January 2007) of diabetes in the same age
groups as the two Swedish studies as well as the Finnish study
and found significantly higher prevalence (6.8% vs 3.7% in
Iliadou et al. [22], 4.9% vs 3.7% in Johansson et al. [21], and
6.5% vs 2.7% in Kaprio et al. [23]) in our data. The
differences persisted throughout the age range. These differ-
ences may be due to a higher diabetes prevalence in the
Danish population, but more likely the discrepancy is caused
by the use of different criteria for defining diabetes cases in
the three studies as well as a higher diagnosis frequency and/
or prevalence of type 2 diabetes in more recent years
compared with preceding years.
In summary, the results of Danish, Italian and New
Zealand small-scale clinical examinations of twins and
singletons have demonstrated adverse effects of twin status
on outcomes related to type 2 diabetes, but large register
Table 3 Model-fit statistics of 10 year period diabetes prevalence among 8,092 MZ twin pairs and 12,557 ssDZ twin pairs from Danish birth
cohorts 1910–1989
Model-fit statistics Malesa Femalesb
vs Δχ2 Δdf AIC p value vs Δχ2 Δdf AIC p value
ACE Satc 0.67 3 −5.33 0.88 Satc 0.01 2 −3.99 >0.99
ADE Satc 0.63 3 −5.37 0.89 Satc 0.91 2 −3.09 0.64
AE ADE 0.04 1 −7.33 0.85 ACE 0.90 1 −5.09 0.82
CE ACE 70.3 1 63.0 <0.01 ACE 28.2 1 22.2 <0.01
E AE 432 1 423 <0.01 AE 27.3 1 255 <0.01
a Equal thresholds for MZ and ssDZ twins
b Unequal thresholds for MZ and ssDZ twins
c Saturated model (model without any constraints)
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studies based on Nordic twin registries have not supported
these findings. Furthermore, the hypothesis of MZ twins
having an increased risk of developing type 2 diabetes
compared with DZ twins [15, 24] has not been supported
by large-scale register studies based on twin registries [21–
23, 42]. The conflicting results may be attributable to
differences in mortality patterns in the Nordic countries as
Denmark lags behind Sweden (for both sexes) and Finland
(only for females) in life expectancy [43, 44], even though
these differences are partly explained by a higher smoking
frequency in Denmark [28, 29]. The present study supports
the results of previous register-based studies; only small
and mainly statistically non-significant differences of
diabetes prevalence in Danish birth cohorts 1910–1989
between twin/singleton and MZ/DZ were found. Further-
more, the Swedish and Finnish studies did not examine the
data for possible birth cohort effect on twin–singleton
differences. The present study demonstrates that the overall
diabetes 10 year period prevalence is similar for twins and
singletons. The only differences in multiple testing is a
tendency towards a higher diabetes prevalence among twins
compared with singletons in older birth cohorts—especially
for males—and the reverse tendency is observed in more
recent birth cohorts—especially for females. Most of these
small differences are statistically non-significant.
The restriction of the analyses to birth cohorts 1921–
1940 revealed a slightly higher, but statistically insignifi-
cant, diabetes occurrence among male twins compared with
male singletons, but no difference was observed for
females. Hence, our study does not support the previous
findings of a higher risk of diabetes among twins compared
with singletons in birth cohorts 1921–1940. In the multiple
testing we only find a statistically non-significant tendency
towards a higher 10 year period diabetes prevalence among
MZ twins compared with DZ twins in these birth cohorts.
The difference is small and statistically insignificant and is
not observed in either older birth cohorts (1910–1919) or
younger birth cohorts (1940–1979; Fig. 3).
It is well known that twins are, on average, smaller at birth
than singletons, thus the concern about long-term health
consequences for twins seems reasonable. Size at birth is an
insufficient measure of fetal growth; it does not provide any
information of the underlying reason or the timing of the
occurrence that affected the shifts in the fetal growth. It seems
plausible that twins are smaller at birth mainly because of
shorter gestational age as well as intra-uterine space restriction
rather than undernutrition, and therefore twins have no
elevated risk of developing type 2 diabetes.
Heritability
Heritability of cumulative incidence of type 2 diabetes
based on the Finnish Twin Registry has been estimated
twice. In 1992 Kaprio et al. [23] demonstrated that additive
genetic effects explained 79% of the variance in females
and 69% in males. When estimated 18 years later, the
heritability had changed slightly (females 64%; males 73%)
[42]. In the present study the estimated heritability of
10 year prevalence of diabetes in the Danish twin
population was at a size comparable with data in the
Finnish studies: 71% in females and 79% in males.
Strengths
A major strength of the present study is the large sample size,
which enables the detection of even small differences as
reflected in the narrow confidence intervals. The sample
comprises all twins as identified in the Danish Twin Registry
together with a 5% random sample from each birth cohort of
all Danish citizens. The study is based on register data, thus
eliminating selection bias due to non-response and enabling
complete follow-up for non-emigrated (n=283,247 [96.6%])
Danes from the birth cohorts 1910–1989.
Limitations
Our case group consisted of individuals with type 1 and
type 2 diabetes as it is not possible to discriminate
effectively between the two types based on the registries
used by the Danish National Board of Health and in this
study. However, patients with type 1 diabetes only
comprise 5–10% of all diagnosed diabetes cases [45] and
Table 4 Heritability estimates of 10 year period diabetes prevalence among 8,092 MZ twin pairs and 12,557 ssDZ twin pairs from Danish birth
cohorts 1910–1989
Heritability
estimates
(95% CI)
Malesa Femalesb
a2 c2 d2 e2 a2 c2 d2 e2
ACE 0.79 (0.62–0.84) 0.00 (0.00–0.14) – 0.21 (0.16–0.26) 0.61 (0.39–0.76) 0.09 (0.00–0.26) – 0.30 (0.24–0.38)
ADE 0.76 (0.44–0.84) – 0.03 (0.00–0.37) 0.21 (0.16–0.26) 0.71 (0.49–0.77) – 0.00 (0.00–0.23) 0.29 (0.23–0.36)
AE 0.79 (0.74–0.84) – – 0.21 (0.16–0.26) 0.71 (0.64–0.77) – – 0.29 (0.23–0.36)
a Equal thresholds for MZ and ssDZ twins
b Unequal thresholds for MZ and ssDZ twins
2022 Diabetologia (2011) 54:2016–2024
the conclusions did not alter when we repeated the analyses
for a subgroup of those known to have type 2 diabetes
(namely those who had ever received glucose-lowering
medical treatment and/or been assigned the diagnosis non-
insulin dependent diabetes at discharge from hospital).
Hence, it is unlikely that our results are biased by the
presence of type 1 diabetic patients in the case sample.
Type 2 diabetes is known to be severely under-
diagnosed, thus it is estimated that approximately 60% of
individuals suffering from type 2 diabetes are unaware of
their disease [46]. However, there is no reason to expect
that the twin population should be more under-diagnosed
than the singleton population. On the contrary, it could be
reasoned that a co-twin of a diagnosed twin would be more
inclined to consult the healthcare system than a singleton
with a younger/older sibling who had received a diagnosis,
thus inducing a higher diagnosis frequency among twins
compared with singletons. This bias would induce an
artificial overestimation of the twin–singleton difference in
the direction of a higher prevalence among twins.
There was no physical examination of the individuals
included in our study. Hence, we cannot study the
occurrence of precursors for type 2 diabetes within the
range of the metabolic syndrome. However, a higher 10 year
occurrence of prediabetic conditions within the twin
population would be expected to be followed by a higher
10 year period prevalence of type 2 diabetes.
Left truncation of the data could bias the results as
identification of diabetes cases in our study relied on
survival until the three health registers were up and running
(1 January 1997). However, as is evident from Fig. 1, the
mortality patterns for twins and singletons are similar, and
therefore the left truncation is unlikely to affect twins and
singletons differently.
Register-based information on birthweight in Danish
birth cohorts is only obtainable from 1979 onwards. We
examined the association between diabetes and birthweight
for the birth cohorts 1979–1989 (results not shown); 266
(0.64%) diabetes cases were identified from 41,294
individuals with known birthweights. There was no
evidence of an inverse relationship between birthweight
and risk of diabetes in a cohort analysis nor in an intra-pair
twin analysis. However, the absent association between
birthweight and diabetes prevalence may very well be due
to the young ages (18–28 years at the end of the
observation period) of the individuals in our study.
The Danish national registers used for the present study
do not facilitate a determination of the date of diagnosis
which again is a proxy for the time of the onset of the
disease. Thus, we were not able to perform regression
analyses in order to estimate rate ratios.
We had zygosity information for 90% of the twin pairs,
but the results were nearly identical after exclusion of the
UZ twins. Likewise, restricting the case sample to known
type 2 diabetes cases did not change the conclusions.
Conclusion
Based on the present study of 77,885 twins from birth
cohorts 1910–1989 registered in the Danish Twin Registry
and surviving until 1 January 1997 together with a 5%
random sample of the background population (n=215,264),
we conclude that only small and statistically non-significant
differences are observed in the 10 year period prevalence of
diabetes between these two populations. No differences
between MZ and DZ twins were observed. We observe a
tendency towards a higher 10 year diabetes prevalence
among twins compared with singletons in the older birth
cohorts but the differences are statistically non-significant
despite the large sample sizes.
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